A detailed history of Iron Horse Wealth Management, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Iron Horse Wealth Management, LLC holds 91 shares of GILD stock, worth $7,985. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91
Previous 91 -0.0%
Holding current value
$7,985
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$63.15 - $72.88 $631 - $728
-10 Reduced 9.9%
91 $6,000
Q3 2023

Oct 18, 2023

BUY
$73.94 - $80.67 $3,770 - $4,114
51 Added 102.0%
101 $7,000
Q4 2022

Jan 19, 2023

BUY
$62.32 - $89.47 $2,492 - $3,578
40 Added 400.0%
50 $4,000
Q3 2022

Oct 12, 2022

SELL
$59.54 - $68.01 $2,381 - $2,720
-40 Reduced 80.0%
10 $1,000
Q4 2021

Jan 19, 2022

BUY
$64.88 - $73.64 $2,595 - $2,945
40 Added 400.0%
50 $4,000
Q4 2020

Jan 14, 2021

BUY
$56.65 - $64.55 $566 - $645
10 New
10 $1,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Iron Horse Wealth Management, LLC Portfolio

Follow Iron Horse Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iron Horse Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iron Horse Wealth Management, LLC with notifications on news.